Hematopoietic stem cell mobilization with G-CSF induces innate inflammation yet suppresses adaptive immune gene expression as revealed by microarray analysis

Experimental Hematology

Volumn 35, Issue 9, 2007, Pages 1456-1465

  Buzzeo, Matthew P ^a   Yang, Jie ^b   Casella, George ^b   Reddy, Vijay ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ADAPTIVE IMMUNITY; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; FLOW CYTOMETRY; GENE EXPRESSION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE SYSTEM; INFLAMMATION; LYMPHOCYTE; MEASUREMENT; MICROARRAY ANALYSIS; MONOCYTE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; STEM CELL MOBILIZATION; T LYMPHOCYTE ACTIVATION; UPREGULATION;

ANTIGENS, CD86; CARRIER PROTEINS; GENE EXPRESSION; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNE SYSTEM; IMMUNITY, NATURAL; INFLAMMATION; MICROARRAY ANALYSIS; RECOMBINANT PROTEINS; UP-REGULATION;

EID: 34548137711     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2007.06.001     Document Type: Article

References (41)

1. Bensinger W.I., Martin P.J., Storer B., et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344 (2001) 175-181
2. Storek J., Dawson M.A., Storer B., et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 97 (2001) 3380-3389
3. Franzke A. The role of G-CSF in adaptive immunity. Cytokine Growth Factor Rev 17 (2006) 235-244
4. Korbling M., Przepiorka D., Huh Y.O., et al. Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts. Blood 85 (1995) 1659-1665
5. Storek J., Gooley T., Siadak M., et al. Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease. Blood 90 (1997) 4705-4709
6. Zhu J., Yamane H., Cote-Sierra J., Guo L., and Paul W.E. GATA-3 promotes Th2 responses through three different mechanisms: induction of Th2 cytokine production, selective growth of Th2 cells and inhibition of Th1 cell-specific factors. Cell Res 16 (2006) 3-10
7. Arpinati M., Green C.L., Heimfeld S., Heuser J.E., and Anasetti C. Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood 95 (2000) 2484-2490
8. Fraser A.R., Cook G., Franklin I.M., et al. Immature monocytes from G-CSF-mobilized peripheral blood stem cell collections carry surface-bound IL-10 and have the potential to modulate alloreactivity. J Leukoc Biol 80 (2006) 862-869
9. Rutella S., Pierelli L., Bonanno G., et al. Role for granulocyte colony-stimulating factor in the generation of human T regulatory type 1 cells. Blood 100 (2002) 2562-2571
10. Reddy V., Hill G.R., Pan L., et al. G-CSF modulates cytokine profile of dendritic cells and decreases acute graft-versus-host disease through effects on the donor rather than the recipient. Transplantation 69 (2000) 691-693
11. Mohty M., Faucher C., and Blaise D. Graft-versus-host-disease and granulocyte colony-stimulating factor administration after allogeneic stem cell transplantation. Leukemia 19 (2005) 500-503
12. Volpi I., Perruccio K., Tosti A., et al. Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants. Blood 97 (2001) 2514-2521
13. Feezor R.J., Baker H.V., Mindrinos M., et al. Whole blood and leukocyte RNA isolation for gene expression analyses. Physiol Genomics 19 (2004) 247-254
14. Reddy V., Iturraspe J.A., Tzolas A.C., et al. Low dendritic cell count after allogeneic hematopoietic stem cell transplantation predicts relapse, death, and acute graft-versus-host disease. Blood 103 (2004) 4330-4335
15. Reiner A., Yekutieli D., and Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 19 (2003) 368-375
16. Tayebi H., Kuttler F., Saas P., et al. Effect of granulocyte-colony stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 29 (2001) 458-470
17. Hernandez J.M., Castilla C., Gutierrez N.C., et al. Mobilisation with G-CSF in healthy donors promotes a high but temporal deregulation of genes. Leukemia 19 (2005) 1088-1091
18. Graf L., Heimfeld S., and Torok-Storb B. Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysis. Biol Blood Marrow Transplant 7 (2001) 486-494
19. Ng Y.Y., van K.B., Lokhorst H.M., et al. Gene-expression profiling of CD34+ cells from various hematopoietic stem-cell sources reveals functional differences in stem-cell activity. J Leukoc Biol 75 (2004) 314-323
20. Rutella S., Zavala F., Danese S., Kared H., and Leone G. Granulocyte colony-stimulating factor: a novel mediator of T cell tolerance. J Immunol 175 (2005) 7085-7091
21. Demetri G.D., and Griffin J.D. Granulocyte colony-stimulating factor and its receptor. Blood 78 (1991) 2791-2808
22. Morikawa K., Morikawa S., Nakamura M., and Miyawaki T. Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes. Br J Haematol 118 (2002) 296-304
23. Franzke A., Piao W., Lauber J., et al. G-CSF as immune regulator in T cells expressing the G-CSF receptor: implications for transplantation and autoimmune diseases. Blood 102 (2003) 734-739
24. Mielcarek M., Graf L., Johnson G., and Torok-Storb B. Production of interleukin-10 by granulocyte colony-stimulating factor-mobilized blood products: a mechanism for monocyte-mediated suppression of T-cell proliferation. Blood 92 (1998) 215-222
25. Rossi M., Arpinati M., Rondelli D., and Anasetti C. Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?. Hum Immunol 63 (2002) 1194-1200
26. Reddy P., Maeda Y., Liu C., Krijanovski O.I., Korngold R., and Ferrara J.L. A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses. Nat Med 11 (2005) 1244-1249
27. Schmaltz C., Alpdogan O., Muriglan S.J., et al. Donor T cell-derived TNF is required for graft-versus-host disease and graft-versus-tumor activity after bone marrow transplantation. Blood 101 (2003) 2440-2445
28. Ewing P., Miklos S., Olkiewicz K.M., et al. Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease. Exp Hematol 35 (2007) 155-163
29. Levesque J.P., Hendy J., Takamatsu Y., et al. Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp Hematol 30 (2002) 440-449
30. Winkler I.G., and Levesque J.P. Mechanisms of hematopoietic stem cell mobilization: when innate immunity assails the cells that make blood and bone. Exp Hematol 34 (2006) 996-1009
31. Velders G.A., van O.R., Hagoort H., et al. Reduced stem cell mobilization in mice receiving antibiotic modulation of the intestinal flora: involvement of endotoxins as cofactors in mobilization. Blood 103 (2004) 340-346
32. van Os R., van Schie M.L., Willemze R., and Fibbe W.E. Proteolytic enzyme levels are increased during granulocyte colony-stimulating factor-induced hematopoietic stem cell mobilization in human donors but do not predict the number of mobilized stem cells. J Hematother Stem Cell Res 11 (2002) 513-521
33. Lindemann A., and Rumberger B. Vascular complications in patients treated with granulocyte colony-stimulating factor (G-CSF). Eur J Cancer 29A (1993) 2338-2339
34. Arimura K., Inoue H., Kukita T., et al. Acute lung injury in a healthy donor during mobilization of peripheral blood stem cells using granulocyte-colony stimulating factor alone. Haematologica 90 (2005) ECR10
35. Madero L., Vicent M.G., Sevilla J., Prudencio M., Rodriguez F., and Diaz M.A. Engraftment syndrome in children undergoing autologous peripheral blood progenitor cell transplantation. Bone Marrow Transplant 30 (2002) 355-358
36. Spitzer T.R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplant 27 (2001) 893-898
37. Vinceti F., Kirkman R., Light S., et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. New Engl J Med 338 (1998) 161-165
38. Lee S.J., Zahrieh D., Agura E., et al. Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial. Blood 104 (2004) 1559-1564
39. Schmaltz C., Alpdogan O., Horndasch K.J., et al. Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect. Blood 97 (2001) 2886-2895
40. Maeda Y., Levy R.B., Reddy P., et al. Both perforin and Fas ligand are required for the regulation of alloreactive CD8+ T cells during acute graft-versus-host disease. Blood 105 (2005) 2023-2027
41. Kim S.H., Han S.Y., Azam T., Yoon D.Y., and Dinarello C.A. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 22 (2005) 131-142